↓ Skip to main content

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

Overview of attention for article published in BMC Palliative Care, September 2009
Altmetric Badge

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain
Published in
BMC Palliative Care, September 2009
DOI 10.1186/1472-684x-8-14
Pubmed ID
Authors

Magdi Hanna, Alberto Tuca, John Thipphawong

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 7%
Unknown 27 93%

Demographic breakdown

Readers by professional status Count As %
Other 4 14%
Student > Master 4 14%
Researcher 4 14%
Student > Bachelor 3 10%
Student > Ph. D. Student 3 10%
Other 8 28%
Unknown 3 10%
Readers by discipline Count As %
Medicine and Dentistry 14 48%
Psychology 6 21%
Nursing and Health Professions 3 10%
Social Sciences 1 3%
Neuroscience 1 3%
Other 1 3%
Unknown 3 10%